June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Influence of Physicochemical Properties on Drug Delivery across Sclera into Choroid-Retina
Author Affiliations & Notes
  • Ayumi Yoshimatsu
    Senju Laboratory of Ocular Sciences, Senju Pharmaceutical Co., Ltd., Kobe, Japan
  • Chiho Yabuta
    Senju Laboratory of Ocular Sciences, Senju Pharmaceutical Co., Ltd., Kobe, Japan
  • Akira Ohtori
    Senju Laboratory of Ocular Sciences, Senju Pharmaceutical Co., Ltd., Kobe, Japan
    Laboratory of Ocular Drug Delivery System, Kyushu Institute of Technology, Fukuoka, Japan
  • Mitsuyoshi Azuma
    Senju Laboratory of Ocular Sciences, Senju Pharmaceutical Co., Ltd., Kobe, Japan
  • Footnotes
    Commercial Relationships Ayumi Yoshimatsu, Senju Pharmaceutical Co., Ltd. (E); Chiho Yabuta, Senju Pharmaceutical Co., Ltd. (E); Akira Ohtori, SENJU PHARMACEUTICAL CO., LTD. (E); Mitsuyoshi Azuma, Senju Pharmaceutical Co., Ltd. (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5057. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ayumi Yoshimatsu, Chiho Yabuta, Akira Ohtori, Mitsuyoshi Azuma; Influence of Physicochemical Properties on Drug Delivery across Sclera into Choroid-Retina. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5057.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Intravitreal injections are currently used to deliver drugs to the retina and other tissues in the back of eye. Topical instillation of ophthalmic drugs would be more comfortable for patients and lower the risk of infection. Reports indicate that topical instillation of some compounds indeed diffuse from the posterior periocular tissues across sclera and reach the posterior choroid-retina. The specific physicochemical properties of such drugs would be important for their permeability, diffusivity and partitioning into ocular tissues, but such data are limited. Thus, the purpose of the present study was to determine the influence of physicochemical properties of selected drugs on their passage across sclera into choroid-retina.

Methods: Model compounds were selected to range in molecular weight (MW) from 300 to 10,000 and included a wide range of lipophilicity. Sclera and sclera-choroid-retina were excised from rabbit globes, and were mounted side-by-side in Ussing diffusion chambers. Model compounds in buffer were added to the donor chamber adjacent to sclera, while buffer solution alone was present in the receptor chamber. Permeation rates, time lags, and permeability across sclera or sclera-choroid-retina preparations were determined by pharmacokinetics modeling. Diffusion and partition coefficients were then calculated based on a bilayer membrane model.

Results: Cumulative transport of drug across sclera and sclera-choroid-retina increased as drug concentration in donor solution increased except for compound of MW 10,000. Permeability was negatively correlated with MW in sclera and sclera-choroid-retina. Drug diffusivity in sclera and choroid-retina decreased as MW increased, and diffusion coefficients in choroid-retina were 3 to 10 times less than that in sclera. Partition coefficients into choroid-retina increased as lipophilicity increased. This relationship was not observed for sclera.

Conclusions: Optimal modification of ocular drugs used for topical instillation needs to decrease MW and to balance solubility with lipophilicity.

Keywords: 688 retina • 452 choroid • 708 sclera  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×